A Case of Diabetic Ketoacidosis Induced by Sodium-Glucose Cotransporter 2 Inhibitor / 임상당뇨병
Journal of Korean Diabetes
;
: 310-314, 2015.
Artículo
en Coreano
| WPRIM
| ID: wpr-726846
ABSTRACT
Sodium-glucose cotransporter 2 (SGLT2) inhibitors are a new class of oral antihyperglycemic drugs; inhibition of the cotransporter allows for increased renal glucose excretion that consequently leads to reduced plasma glucose level. We report a rare case of a 73-year-old woman with type 2 diabetes mellitus who developed severe ketoacidosis caused by an SGLT2 inhibitor. At admission, severe ketoacidosis with arterial PH 6.99 was observed, though her serum glucose level of 232 mg/dL was not excessively high. It is necessary to pay attention to patients with type 2 diabetes being treated with an SGLT2 inhibitor, as anorexia, diarrhea, dehydration, and weight loss can develop in conjunction with a high fat/protein diet.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Asunto principal:
Glucemia
/
Pérdida de Peso
/
Anorexia
/
Cetoacidosis Diabética
/
Deshidratación
/
Diabetes Mellitus
/
Diabetes Mellitus Tipo 2
/
Diarrea
/
Dieta
/
Glucosa
Límite:
Anciano
/
Femenino
/
Humanos
Idioma:
Coreano
Revista:
Journal of Korean Diabetes
Año:
2015
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS